EIR Biopharma, Inc.
CIK: 0001966774
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type other
State of Incorporation DE
Business Address 92 NATOMA ST STE 200, SAN FRANCISCO, CA, 94105
Mailing Address 92 NATOMA ST STE 200, SAN FRANCISCO, CA, 94105
Phone (415) 495-7111
Fiscal Year End 1231
EIN 880595900
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | February 17, 2026 | View on SEC |
IPO Filings
S-1 February 17, 2026
- Developing potentially curative gene therapies for severe, rare genetic diseases.
- Lead candidate EIR-001 in Phase 1/2 trials for Huntington's Disease, with a robust preclinical pipeline.
Related Companies
Companies in the same industry (SIC: 2836)
SANGAMO THERAPEUTICS, INC
SGMO Biological Products, (No Diagnostic Substances)
Zivo Bioscience, Inc.
ZIVO Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX Biological Products, (No Diagnostic Substances)
EXOZYMES INC.
EXOZ Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.